Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunocore Holdings plc

34.62
+0.68002.00%
Volume:170.33K
Turnover:5.85M
Market Cap:1.74B
PE:-80.10
High:36.14
Open:34.00
Low:33.59
Close:33.94
Loading ...

Mizuho Raises Price Target on Immunocore Holdings to $36 From $33, Keeps Neutral Rating

MT Newswires Live
·
28 Jul

BB Biotech AG Reports Q2 2025 Net Loss of CHF 100 Million; USD Share Price Up 10.2%, Currency Drag Impacts CHF Performance

Reuters
·
25 Jul

European Equities Traded in the US as American Depositary Receipts Edge Higher Monday

MT Newswires Live
·
09 Jun

Immunocore Holdings Price Target Maintained With a $100.00/Share by HC Wainwright & Co.

Dow Jones
·
02 Jun

Immunocore Holdings plc to Participate in the 2025 Jefferies Global Healthcare Conference

Reuters
·
02 Jun

Deutsche Bank Initiates Immunocore Holdings at Buy With $65 Price Target

MT Newswires Live
·
27 May

Immunocore Holdings Secures Shareholder Approval at AGM

TIPRANKS
·
16 May

Immunocore Holdings Reports Strong Q1 2025 Performance

TIPRANKS
·
08 May

Mizuho Securities Sticks to Its Hold Rating for Immunocore Holdings (IMCR)

TIPRANKS
·
08 May

Sector Update: Health Care Stocks Gain Wednesday Afternoon

MT Newswires Live
·
08 May

Immunocore Holdings: Strong Sales Growth and Financial Position Justify Buy Rating

TIPRANKS
·
08 May

Immunocore Hldgs Q1 GAAP EPS $0.10 Beats $(0.39) Estimate, Sales $93.88M Beat $88.52M Estimate

Benzinga
·
07 May

Immunocore Holdings' Q1 Swings to Net Income, Revenue Rises

MT Newswires Live
·
07 May

Immunocore Holdings PLC reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

BRIEF-Immunocore Reports First Quarter Financial Results And Provides A Business Update

Reuters
·
07 May

Wall Street Analysts Think Immunocore (IMCR) Could Surge 107.45%: Read This Before Placing a Bet

Zacks
·
30 Apr

Immunocore Holdings Is Maintained at Overweight by JP Morgan

Dow Jones
·
15 Apr

J.P. Morgan Remains a Buy on Immunocore Holdings (IMCR)

TIPRANKS
·
14 Apr

Immunocore Holdings Price Target Maintained With a $71.00/Share by Needham

Dow Jones
·
10 Apr

Mizuho Adjusts Price Target on Immunocore Holdings to $33 From $38, Keeps Neutral Rating

MT Newswires Live
·
07 Apr